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Fig. S3
. Gene expression in the gut of rats monoassociated with R. gnavus E1 and heterologous expression and purification of MBP-mRumC1, mRumC1, and RumPc. (A) mRNA transcripts were purified from caecal contents of rats mono-associated with R. gnavus E1. Expression levels were measured for genes encoding the peptide RumC1, the sactisynthase RumMc1 and the peptidase RumPc. Expression levels for the genes of interest were normalised against expression of rpoB. Table S1 for theoretical and observed masses of interest). (A) MS/MS spectrum of the Q(-10)-A20 fragment of mRumC1-C3A highlighting the presence of a unique thioether bridge between C5 and A12. The intense y9 fragment highlights the presence of a thioether bridge involving A12. (B) MS/MS spectrum of the A17-A44 fragment of mRumC1-C22A highlighting the presence of a unique thioether bridge between C26 and R34. (C) MS/MS spectrum of the F(-5)-A20 fragment of mRumC1-C5A revealing alkylation of C3. (b* corresponds to a b fragmentation with a loss of NH3 due to the presence of Q). and that of the preceding residue (C i-1 ). The sequential connectivities (HN i -C i-1 ) are indicated in green. Amino acids bridged via thioether bonds are shown in red and Cys partners are shown in blue. Note the large downfield shifts at 72.2, 68.6, 74.5 and 75.5 ppm for -carbons of A12, N16, R34 and K42 residues, respectively. (B) Three (bottom)). (D) RP-C 18 HPLC chromatograms of a kinetic study for the removal of the leader peptide of mRumC1 (see pic at 20 min) by trypsin leading to the mRumC1cc form (see pic at 9 min), duration of treatment with trypsin is indicated vertically, NT = no treatment. Peptides were detected at 214 nm in HPLC output.
Fig. S8. Evaluation of the ability of RumC1 to insert into bacterial lipids.
Total lipids from C. perfringens ATCC 13124 were extracted as described in the Supplementary Methods section. Total lipid extract was spread at the air-water interface until the surface pressure (p) reached approximatively 30 mN/m. Tested molecules were then injected into the aqueous subphase and the insertion into lipids was followed through the continuous measurement of the surface pressure (p). The detergent cetyl trimethylammonium bromide (CTAB) and the pore-forming antimicrobial peptide Nisin were used as positive controls. CTAB was used at 100 µM whereas Nisin and RumC1 were assayed at 10 x MIC, i.e. 7.8 µM and 15.6 µM, respectively. Graph shown is representative of three independent experiments. 
Supplementary Methods

RNA extractions and real-time PCR
RNA was extracted from the faeces of two R. gnavus E1 mono-associated rats collected before and after 12 days of colonization. Faecal samples were thawed in 1 mL RNApro solution containing lysing matrix E (MP Biomedicals). The cells were homogenized in a Fast Prep FP120 cell homogenizer (Thermo Savant) for 2 cycles of 40 s at 6.0 m.s −1 . RNA was extracted from the aqueous phase by chloroform extraction and ethanol precipitation before being treated twice with DNase I (NEB). No bacterialRNA could be detected in the faeces of rats before colonization. cDNA was generated using the SuperScript VILO kit (Invitrogen, Thermo Fisher Scientific). Real-time PCR amplification was performed using the LightCycler 480 Instrument and SYBR Green I Master (Roche) on 10 ng cDNA per reaction in the presence of 0.5 µM of each forward and reverse primers (Invitrogen) ( fig. S1B ). PCR amplification was initiated at 95 °C for 10 min, followed by 45 cycles of 9 5 °C for 10 s, 60 °C for 10 s and 72 °C for 10 s. A melting curve was added at the end of the amplification to confirm primer specificity. All reactions were performed in duplicate and repeated five times.
Fold change in R. gnavus E1 transcript amounts was determined using the 2-ΔCt method (58), using rpoB as the reference gene.
Peptide synthesis
The linear RumC1 peptide was prepared by solid phase peptide synthesis in an Initiator + Alstra automated microwave assisted synthesizer (Biotage). The peptide was assembled on a Fmoc Ala Wang resin (0.125 mmol scale, 0.53 mmol/g) using standard Fmoc methodologies (59). After assembling, the peptide was manually deprotected and cleaved from the resin by treatment with the mixture TFA/TIS/water (%v/v = 95:2.5:2.5) for 2 h at room temperature and under nitrogen. The resin was filtered out and rinsed with TFA. The filtrate and rinses were combined and reduced under a nitrogen stream. Cold diethyl ether was added to precipitate the crude peptide, which was dissolved in the minimum amount of water and lyophilized. The crude peptide was purified by preparative reversed-phase HPLC in a Phenomenex Jupiter column (250 mm × 21.20 mm, 15 μm, 300 Å) using solvent A (99.9% water/0.1 % TFA) and solvent B (90% ACN/9.9% water/0.1 % TFA). The RumC1 peptide was eluted from the column with a linear gradient from 23.5% to 24.5% B at a flow rate of 10 mL/min. Its purity was checked by analytical reversed-phase HPLC (Phenomenex Jupiter column, 250 mm × 4.6 mm, 15 μm, 300 Å) and it was greater than 98%. The peptide was characterized by Electrospray Ionization-Mass spectrometry (ESI-MS) in positive mode using an online nano-LC−MS/MS (NCS HPLC, Dionex, and Qexactive HF, Thermo Fisher Scientific).
Site directed mutagenesis of mRumC1
Site directed mutagenesis of the MBP-RumC1 construct was performed following instructions from the Q5 Site-Directed Mutagenesis Kit (New England BioLabs ® ). The NEBaseChanger tool was used to generate primer sequences ( fig. S1B ) and annealing temperatures for each Cys to Ala single mutant. Template plasmids were digested using DpnI and were transformed into competent Top10 cells. The mutant plasmids were recovered from cells by using the Wizard ® Plus SV Minipreps DNA Purification System (Promega).
Cysteine Alkylation
Ammonium bicarbonate was added to a solution of MBP-mRumC1 (or MBP-mRumC1 mutants) at a concentration of 100 mM. Dithiothreitol was added to this solution at a concentration of 5 mM and subsequently incubated at 55 °C for 35 min. Iodoacetamide was added at a final concentration of 14 mM to alkylate free cysteine and the solution was further incubated at room temperature for 30 min in the dark. To quench unreacted iodoacetamide, dithiothreitol was added to this solution at a concentration of 5 mM and incubating at room temperature for 15 min in the dark. The solution was collected and analysed by LC-MS.
Isotopic labeling of mRumC1
A synthetic plasmid containing the E. coli codon-optimized gene of R. gnavus E1 encoding RumMc1 (pET-15b-rumMc1, ampicillin-resistant) was obtained from Genscript. Plasmids pET-15b-rumMc1, pETM-40-rumC1 and psuf (chloramphenicol-resistant) containing sufABCDSE genes were used to transform competent E. coli BL21 (DE3) cells. The resulting strain was grown in 3 L of M9 medium containing kan (50 μg/mL), amp (100 μg/mL), chl (34 μg/mL), vitamin B1 (0.5 μg/mL), MgSO 4 (1 mM), FeCl 3 (50 µM) and glucose (4 mg/mL) at 37 °C. At an optical density (OD 600 ) of 0.25, cells were harvested by centrifugation (4,000 rpm for 20 min at 4°C). The cells were resuspended in 1 L of labeled minimal medium (Na 2 HPO 4 6 g/L, KH 2 PO 4 3 g/L, 15 NH 4 Cl 1 g/L) containing kan (50 μg/mL), amp (100 μg/mL), chl (34 μg/mL), vitamin B1 (0.5 μg/mL), MgSO 4 (1 mM), FeCl 3 (50 μM) and labeled glucose-13 C (4 mg/mL). The culture was grown at 25°C to an optical density (OD 600 ) of 0.8. FeCl 3 (100 μM) and L-cysteine (300 μM) were then added and the culture was induced with 1 mM IPTG. The cells were grown for 15h under stirring and then were harvested by centrifugation (4,000 rpm for 20 min at 4°C). Labeled mRumC1 was purified as described for the unlabeled sample.
NMR of RumC1
NMR experiments were conducted at 27°C, by using a 15 N, 13 C-labeled RumC1 sample of 0.2 mM in 10 mM phosphate buffer, pH 6.8, in H2O. NMR data were acquired using a Bruker Avance III 600 MHz spectrometer equipped with a cryogenically cooled triple resonance 
Lipid insertion assay
Lipid insertion was measured using reconstituted lipid monolayer at the air-water interface as previously described (54, 58) . Total lipids were extracted from 3 mL of an overnight culture of C. perfringens ATCC 13124 as previously described (58). Extracted total lipids were dried, resolubilized in chloroform:methanol (2:1, v:v) and store at -20 °C under nitrogen. For lipid insertion assay, total lipid extract was spread using a 50 µL Hamilton's syringe at the surface of 700 µL of sterile PBS creating a lipid monolayer at the air-water interface. Lipids were added until the surface pressure reached approximatively 30 mN/m, this surface pressure corresponding to a lipid packing density theoretically equivalent to that of the outer leaflet of the cell membrane (54). Lipid insertion of tested molecules was evaluated by injecting them directly into the 700 µL sub-phase of PBS under the lipid monolayer (pH 7.4, volume 800 µL) using a 10 µL Hamilton syringe. Tested molecules were: i) the detergent Cetyl trimethylammonium bromide (CTAB) (at a final concentration of 100 µM), ii) the poreforming antimicrobial peptide Nisin (at a final concentration of 7.8 µM, corresponding to 10times its MIC) and iii) RumC1 (at a final concentration of 15.6 µM, corresponding to 10times its MIC). The variation of the surface pressure caused by the insertion of the molecules into the lipid monolayer was then continuously monitored using a fully automated microtensiometer (µTROUGH SX, Kibron Inc., Helsinki, Finland) until reaching equilibrium.
